RespiPoints

After successful pilot, Boehringer Ingelheim, HealthPrize roll out digital adherence tool more broadly
By Dave Muoio | 02:28 pm | April 19, 2018
Following a successful nine-month pilot, Boehringer Ingelheim and HealthPrize Technologies announced that the digital adherence support program RespiPoints will be expanded to any patient who is taking certain Boehringer Ingelheim medications, including some available in the Respimat inhaler.